BioLife Solutions Executives Sell Shares
| Reporter Name | Relationship | Type | Amount | SEC Filing |
|---|---|---|---|---|
| Wichterman Troy | Chief Financial Officer | Sell | $20,696 | Form 4 |
| Mathew Aby J. | EVP & Chief Scientific Officer | Sell | $12,663 | Form 4 |
Troy Wichterman, Chief Financial Officer of BioLife Solutions, sold 894 shares of common stock on October 30, 2024, at a price of $23.15 per share, totaling $20,696. Following the transaction, Wichterman directly owns 123,494 shares of the company. The sale was conducted under a Rule 10b5-1(c) trading plan adopted on January 3, 2023.
Mathew Aby J., EVP & Chief Scientific Officer of BioLife Solutions, sold 547 shares of Common Stock on October 30, 2024, at a price of $23.15 per share, totaling $12,663. Following the transaction, Mathew Aby J. directly owns 317,169 shares of the company. The sale was conducted under a Rule 10b5-1(c) trading plan adopted on January 3, 2023.